GINA OBSENARES: Open Payments
NPI 1871703777 · BURBANK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,723 in 152 payments from 17 companies in 2025. Trend: 2023 $4,318 · 2024 $11,092 · 2025 $5,723
Food & beverage: $4,193Speaker / faculty: $923Consulting: $588Travel & lodging: $20
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 12 | $1,696 |
| ABBVIE INC. | 45 | $989 |
| Arcutis Biotherapeutics, Inc. | 16 | $654 |
| GENZYME CORPORATION | 17 | $632 |
| Incyte Corporation | 13 | $381 |
| Regeneron Healthcare Solutions, Inc. | 7 | $258 |
| Novartis Pharmaceuticals Corporation | 9 | $237 |
| Botanix SB Inc | 7 | $175 |
| UCB, Inc. | 5 | $142 |
| Organon LLC | 2 | $129 |
Products named: ADBRY, DUPIXENT, Zoryve, SKYRIZI, OPZELURA, BOTOX, COSENTYX, SOFDRA.
Industry payments across CA — which companies pay providers there.
